loader
Please Wait
Applying Filters...

Looking for Controlled & Modified Release? Find Controlled & Modified Release Agents used in Budesonide to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 3,439Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Evonik

02 5Gangwal Healthcare

03 5Nanjing Well Pharmaceutical

04 6Actylis

05 2Aeon Procare

06 3Alcedo Pharmachem

07 21BASF

08 3Corel Pharma Chem

09 4Finar

10 2Gangwal Chemicals

11 4Ideal Cures Pvt Ltd

12 15Kerry

13 1Kima Chemical

14 1Lonza Capsugel

15 2Nomisma Healthcare

16 1Sigachi Industries

17 5The Dow Chemical Company

18 6Vertellus

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Brand : EUDRAGIT® L 100-55

Applications : EUDRAGIT® L 100-55 polymer is used in delayed, sustained-release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as powder; Other grades- EUDRAGIT® L 30 D-55

Grade : Oral

arrow

03

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Grade : Parenteral, Topical, Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Brand : GELLETS-P®

Applications : Gellets-P are Microcrystalline Cellulose based spheres for the manufacturing of pellets and modified release products.

Pharmacopoeia Ref : In-house

Technical Specs : NA

Grade : Oral

arrow

05

arrow
2024 ACI Convention
Not Confirmed

06

arrow
2024 ACI Convention
Not Confirmed

07

arrow
2024 ACI Convention
Not Confirmed

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

09

arrow
2024 ACI Convention
Not Confirmed

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : PLGA-PEG

Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

Grade : Oral, Parenteral

arrow

Brand : PLGA-PEG

Applications : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

Grade : Oral, Parenteral

arrow
blank

11

arrow
2024 ACI Convention
Not Confirmed

14

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : ESPHERES EM

Applications : These spheres can be used as an inert base for modified release formulations promoting consistency and uniformity of release profile thus ensuring a uniform therapeutic response.

Pharmacopoeia Ref : Particle Sizes - #20 – #30, #30 – #40 and #40 – #60

Technical Specs : Not Available

Grade : Oral

arrow
blank

18

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : METHOCEL™

Applications : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

Pharmacopoeia Ref : Not Available

Technical Specs : Not Available

Grade : Not Available

arrow
blank

23

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

24

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

26

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : VCAPS® ENTERIC

Applications : It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.

Pharmacopoeia Ref : Complies with relevant European, Japanese and US Pharmacopeia monographs

Technical Specs : Water content – less than 6%; Size #0

Grade : Oral

arrow
blank

29

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

31

arrow
2024 ACI Convention
Not Confirmed

38

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : KOLLICOAT SR 30 D

Applications : pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

Pharmacopoeia Ref : Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

Technical Specs : Not Available

Grade : Not Available

arrow
blank

39

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : NUTRACOAT EC25D

Applications : Sustained Release, Taste Masking, Moisture Barrier, Binder in Wet Granulation

Pharmacopoeia Ref : USP/NF: Ethyl cellulose dispersion Type B

Technical Specs : Not Available

Grade : Oral

arrow
blank

40

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : KOLLICOAT MAE 100-55

Applications : Enteric coating with release above pH 5.5 (non-neutralized powder), fast redispersing for aqueaous and organic coating

Pharmacopoeia Ref : Not Available

Technical Specs : Not Available

Grade : Not Available

arrow
blank

41

arrow
2024 ACI Convention
Not Confirmed

42

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : KOLLICOAT MAE 30 DP

Applications : Enteric coating with release above pH 5.5 (30 % solids content dispersion)

Pharmacopoeia Ref : Ph. Eur.: Methacrylic Acid

Technical Specs : Not Available

Grade : Not Available

arrow
blank

43

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : Soluplus

Excipient Details : Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

Pharmacopoeia Ref : Polyvinyl caprolactam – poly...

Technical Specs :

Grade :

arrow

Brand : SOLUPLUS

Applications : Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

Pharmacopoeia Ref : Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer

Technical Specs : Not Available

Grade : Not Available

arrow
blank